Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis2017 · 108 citations
2. 2Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS2005 · 79 citations
3. 3Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)2014 · 226 citations
4. 4Characterization of Neuronal Intermediate Filament Protein Expression in Cervical Spinal Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis (ALS)2000 · 177 citations
5. 5Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression2012 · 157 citations